Medical termination in dogs treatment and caution
Reading File
Finding Sources
Searching PubMed
pregnancy termination dogs aglepristone prostaglandin
Finding Sources
Finding Sources
Searching PubMed
canine pregnancy termination aglepristone cabergoline
Finding Sources
Finding Sources
Searching the Web
medical termination of pregnancy in dogs drugs treatment protocol caution 2024
Reading Web Page
https://www.merckvetmanual.com/management-and-nutrition/mana…
Finding Sources
Good - I now have comprehensive information from the Merck Veterinary Manual (updated June 2025) and supporting sources. Here is a thorough answer:
Medical Termination of Pregnancy in Dogs (Bitches)
Important: Always confirm pregnancy before treating - 60% of mismated bitches do not conceive. Unnecessary administration of abortifacient drugs carries serious risks. All protocols should be performed under veterinary supervision.
When to Consider Medical Termination
Medical termination is indicated in confirmed unwanted/mismated pregnancies when the owner does not consent to ovariohysterectomy (spay) or when future breeding is desired. Timing of treatment affects drug choice and success rate:
- Early (post-coital/pre-implantation): Before Day 20-25 (estrogens were historically used here but are now discouraged)
- Mid-gestation (confirmed pregnancy): Days 25-45 - best window for medical management
- Late gestation (Day 45+): Harder to manage medically; expulsion of formed fetuses likely
Drug Protocols
1. Prostaglandin F2-alpha (Dinoprost / PGF2α)
Drug: Dinoprost tromethamine (natural PGF2α)
| Parameter | Detail |
|---|---|
| Dose | 0.1 mg/kg SC q8h for 48 hours, then 0.2 mg/kg SC q8h to effect |
| Duration | Until ultrasonographic confirmation of fetal evacuation |
| Mechanism | Luteolysis (destroys corpus luteum) → progesterone withdrawal → uterine contractions |
| Efficacy | Effective from ~Day 25 onward |
Side effects (common, transient, begin within minutes): panting, salivation, trembling, vomiting, diarrhea, urination, mydriasis, ataxia, vocalization. Side effects subside within 30-60 minutes.
Cautions:
- Hospitalize the dog for the first few injections to monitor for severe reactions
- Narrow therapeutic window - calculate doses carefully by exact body weight
- Do NOT use in dogs with respiratory disease, cardiovascular disease, or gastrointestinal disorders
- Not effective before Day 25 (corpus luteum is refractory early in diestrus)
2. Synthetic Prostaglandin - Cloprostenol (PREFERRED)
Drug: Cloprostenol (synthetic PGF2α analogue)
| Parameter | Detail |
|---|---|
| Dose | 1-2.5 mcg/kg SC every 12-24 hours to effect |
| Alternative combination dose | 2.5 mcg/kg SC once (when combined with cabergoline) |
| Mechanism | More specific to myometrium than natural PGF2α |
Advantages over natural PGF2α:
- Fewer systemic side effects (more uterus-selective)
- Less frequent dosing needed
- Currently the preferred prostaglandin
3. Dopamine Agonist - Cabergoline (PREFERRED in combination)
Drug: Cabergoline
| Parameter | Detail |
|---|---|
| Dose | 5 mcg/kg PO daily (divided into 2 doses q24h) for 5+ days |
| Mechanism | Inhibits prolactin secretion → luteolysis (dogs are prolactin-dependent for luteal maintenance) |
| Alone: | >50% effective only from Day 40+; less reliable before Day 40 |
Advantages: Minimal side effects at therapeutic doses; oral administration
4. Combination Protocol: Cabergoline + Cloprostenol (Most Effective)
| Parameter | Detail |
|---|---|
| Cabergoline | 5 mcg/kg PO, divided into 2 doses q24h |
| Cloprostenol | 2.5 mcg/kg SC once (or q24-48h depending on protocol) |
| Efficacy | Highest success rates, shortest treatment time, minimal adverse effects |
| Disadvantage | Cost; may require compounding |
This combination uses dual luteolytic mechanisms (antiluteotrophic + direct luteolysis), which lowers the required dose of each drug and reduces side effects. This Merck Veterinary Manual (Jun 2025) is the currently preferred protocol.
5. Dexamethasone (Glucocorticoid)
Drug: Dexamethasone
| Parameter | Detail |
|---|---|
| Dose | 0.2 mg/kg PO every 12 hours to effect (typically ~10 days) |
| Mechanism | Not fully understood; works later in gestation |
| Efficacy | Reliable in dogs; NOT effective in cats |
Cautions:
- Panting, polyuria, polydipsia, immunosuppression (all owner-counseling points)
- Works primarily in late gestation - expulsion of formed fetuses is likely, which can be distressing to owner and animal
- Treatment time up to 14 days
- Can be combined with misoprostol (1-3 mcg/kg intravaginally q24h) to shorten treatment by ~48 hours
6. Aglepristone (Antiprogestin) - Where Available
Drug: Aglepristone (not commercially available in the USA but used in Europe)
| Parameter | Detail |
|---|---|
| Dose | 10 mg/kg SC on Days 1 and 2 (repeat on Day 7-8 if needed) |
| Mechanism | Competitive progesterone receptor antagonist → progesterone withdrawal |
| Best used | Before Day 45; earlier = more likely resorption rather than fetal expulsion |
Cautions: Not licensed in all countries; monitor for incomplete abortion
Drugs to AVOID
| Drug | Reason to Avoid |
|---|---|
| Injectable estrogens (e.g., estradiol cypionate) | Pyometra risk up to 25%, potentially fatal bone marrow suppression, prolonged estrus |
| Oral estrogens during diestrus | Unreliable, high pyometra risk - NOT advised |
| Postcoital douches | No value in preventing pregnancy |
| Bromocriptine (vs cabergoline) | More side effects (nausea, vomiting); cabergoline preferred |
General Cautions and Monitoring
- Confirm pregnancy first - relaxin test, ultrasound, or progesterone levels before treating. Never treat a non-pregnant animal with abortifacients.
- Ultrasound monitoring - confirm complete fetal/placental evacuation after treatment. Incomplete abortion can cause septicemia and pyometra.
- Gestational age matters - treatment before Day 25 often ineffective for prostaglandins; very early termination with aglepristone or combination protocols may result in resorption (clean), while late termination results in fetal expulsion (messy, potentially traumatic).
- Pyometra risk - any hormone manipulation during diestrus carries a background risk of pyometra. Monitor for signs (vaginal discharge, lethargy, PU/PD, vomiting) for 4-8 weeks post-treatment.
- Operator safety - prostaglandins are absorbed transdermally and can cause bronchospasm, especially dangerous for asthmatic individuals. Always wear gloves and avoid skin contact.
- Future fertility - most protocols do not permanently affect future fertility when used correctly.
Summary Table
| Drug | Route | Stage | Efficacy | Main Side Effects |
|---|---|---|---|---|
| PGF2α (dinoprost) | SC | Day 25+ | Good | Panting, vomiting, diarrhea, trembling |
| Cloprostenol | SC | Day 25+ | Good-Excellent | Milder than natural PGF |
| Cabergoline alone | PO | Day 40+ | >50% | Minimal |
| Cabergoline + cloprostenol | PO + SC | Day 25+ | Excellent | Minimal |
| Dexamethasone | PO | Late gestation | Good (dogs only) | PU/PD, panting, immunosuppression |
| Aglepristone | SC | Before Day 45 | Good | Injection site reaction |
| Estrogens | IM | Post-coital | Unreliable | Pyometra, aplastic anemia - NOT recommended |
Sources: Merck Veterinary Manual, Jun 2025; Gobello C. (2006), Theriogenology [PMID: 16542717]; Eilts BE. (2002), Clin Tech Small Anim Pract [PMID: 12476814]
This is a shared conversation. Sign in to Orris to start your own chat.